期刊文献+

内皮抑素治疗人骨肉瘤裸鼠模型的实验研究 被引量:3

Effects of Endostatin Treatment on Human Osteosarcoma Xenografts in Nude Mice
下载PDF
导出
摘要 目的:观察内皮抑素(ES)对裸鼠骨肉瘤皮下移植模型血管生成和肿瘤生长的抑制作用及其机制。方法:Transwell双室模型观察ES对骨肉瘤细胞9901诱导内皮细胞迁徙的影响;随机将30只骨肉瘤荷瘤裸鼠分为对照组、ES低剂量组[0.75mg(kg·d)-1]和高剂量组[1.5mg(kg·d)-1],瘤体及瘤体周围注射ES,1次/d,连续给药14d,观察肿瘤生长情况,计算抑瘤率。肿瘤组织进行病理学观察及免疫组化染色,计数坏死组织百分比,微血管密度以及细胞增殖和凋亡指数;动物处死前3个小时尾静脉注射EF5,激光共聚焦显微镜观察组织缺氧及血管标记。结果:ES低剂量组(350ng·ml-1)和高剂量组(700ng·ml-1)对内皮细胞迁徙有明显抑制作用,且高剂量组明显高于低剂量组(P<0.01);高剂量组和低剂量组平均瘤重明显小于对照组,抑瘤率分别为35.83%和22.92%(P<0.01);正常对照组、低剂量组、高剂量组的坏死百分比分别为2.40%、4.68%和9.52%(P<0.01),细胞增殖指数(PI)分别为66.44%、46.11%和25.11%(P<0.01),细胞凋亡指数(AI)分别为2.69%、7.58%和11.53%(P<0.01)。激光共聚焦观察ES治疗组绿色荧光量减少,血管稀疏;肿瘤细胞缺氧增加,呈弥漫的强红色。结论:ES可显著地抑制骨肉瘤细胞诱导的内皮细胞迁徙,以及人骨肉瘤的生长和发展,且呈剂量依赖效应,其可能机制为抑制血管生成,增加肿瘤细胞缺氧和凋亡。 Objective: To evaluate the inhibitory action of endostatin (ES) on human osteosarcoma tumor growth in nude mice and its possible mechanism. Methods: The inhibitory role of ES on endothelial cell migration induced by osteosarcoma cell line 9901 was observed using a transwell model. Thirty Balb/c nu/nu mice implanted with osteosarcoma were randomly divided into the control, ES low dose (0.75 mg/Kg.d) and ES high dose (1.5 mg/Kg.d) groups. ES was injected intratumorally and around the tumor, once a day for 14 days. The tumor volumes were measured and the tumor inhibition rate (TIR) was calculated, The percentages of necrotic tissue, microvessel density, proliferation index (PI) and apoptotic index (AI) were detected by pathohistologic observation and immunohistochemical staining. The mice were sacrificed 3 h after EF5 injection via tail vein, and then the hypoxia of tumor cells and microvessels was observed using laser confocal microscopy. Results: Both the low dose (350 ng/ml) and high dose (700 ng/ml) ES groups showed a marked inhibition of endothelial cell migration induced by osteosarcoma cells, while the high dose showed much stronger inhibition than the low dose (P〈0.01). The tumor volume was significantly different among the 3 groups. The TIR in the high dose and the low dose groups were 35.8% and 22.9%, respectively. In the control group, the ES low dose group and the ES high dose group, the percentage of necrotic tissue was 2.40%, 4.68% and 9.52%, the PI was 66.44%, 46.11% and 25.11%, and the AI was 2.69%, 7.58% and 11.53%, respectively (P〈0.01). Much less green fluorescence (microvessel) and stronger red fluorescence (hypoxia) were apparent in the tumors treated with ES when observed with laser confocal microscopy. Conclusions: The results show that ES markedly inhibits endothelial cell migration in vitro and significantly restrains the growth and development of osteosarcoma in vivo. The mechanism may be due to anti-angiogenesis properties associa
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第1期52-55,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30340044 30472004)
关键词 骨肿瘤 内皮抑素 血管生成 Bone tumor Endostatin Angiogenesis
  • 相关文献

参考文献13

  • 1王东,陈俐,高奉浔.骨肉瘤中微血管密度与预后的研究[J].中华病理学杂志,1997,26(5):266-269. 被引量:30
  • 2李颖嘉,王东,高奉浔.血管内皮生长因子抗体治疗骨肉瘤的实验研究[J].中华外科杂志,2002,40(3):225-228. 被引量:14
  • 3Evans SM, Koch GJ. Prognostic significance of tumor oxygenation in humans[J]. Cancer Lett, 2003, 195(1):1-16 被引量:1
  • 4Tjin Tham Sjin R_M, Satchi-Fainaro R, Birsner A.E, et al. A 27-amino-acid synthetic pepfide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity[J]. Cancer Res, 2005, 65(9):3656-3663 被引量:1
  • 5Marneros AG, Olsen BR. Physiological role of collagen ⅩⅧ and endostatin[J]. FASEBJ, 2005, 19(7):716-728 被引量:1
  • 6O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997, 88(2) :277 -285 被引量:1
  • 7Uematsu S, Higgashi T, Nouso K, et al. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostadn in patients with hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2005, 20(4):583-588 被引量:1
  • 8Graepler F, Verbeek B, Graeter T, et al. Gombined endostatin/sFl--1 antianglogenic gene therapy is highly effecdve in a rat model of HGG[J]. Hepatology, 2005, 41(4):879-886 被引量:1
  • 9刘江秋,李忠义,陈林生,孙亦红,徐璐,汪军远,刘万兴,夏结来.重组人血管内皮抑制素抗肿瘤效应的应用研究[J].细胞与分子免疫学杂志,2001,17(1):63-64. 被引量:15
  • 10Te Velde EA, Reijerkerk A, Brandsma D, et al. Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the fiver and their adhesion to endothelial cells [J]. Br J Gancer, 2005, 92(4):729-735 被引量:1

二级参考文献5

共引文献55

同被引文献26

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部